Misfolded α-synuclein aggregates are transmitted via exosomes from donor to recipient neurons, templating endogenous aSyn misfolding through a 'prion-like' mechanism that explains Braak staging progression patterns. This hypothesis is biologically plausible but causally unproven—the exosome field struggles to distinguish propagation vectors from secondary clearance mechanisms. Druggability is severely constrained by the essential physiological functions of exosomes (synaptic function, immune sur
## Mechanistic Overview
Rab27A/B-mediated exosomal tau secretion from microglia drives frontal cortex propagation at Braak III-VI starts from the claim that modulating RAB27A within the disease context of neurodegeneration can redirect a disease-relevant process. The original description reads: "## Mechanistic Overview Rab27A/B-mediated exosomal tau secretion from microglia drives frontal cortex propagation at Braak III-VI starts from the claim that modulating RAB27A within the disease context o
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
RAB27A recurs across 2 selected hypotheses with aligned directionality in biomarker, unspecified mechanism.
Divergent signals
No direct polarity conflicts detected among the selected hypotheses.
Verdict Summary
5/11
dimensions won
Exosomal α-Synuclein as an Interneuronal
9/11
dimensions won
Rab27A/B-mediated exosomal tau secretion
Radar Chart — 10 Dimensions
Score Comparison Bars
Mechanistic
0.72
0.72
Evidence
0.75
0.66
Novelty
0.80
0.70
Feasibility
0.45
0.70
Impact
0.55
0.70
Druggability
0.40
0.65
Safety
0.35
0.70
Competition
0.65
0.65
Data
0.70
0.75
Reproducible
0.58
0.70
KG Connect
0.50
0.50
Score Breakdown
Dimension
Exosomal α-Synuclein as an Int
Rab27A/B-mediated exosomal tau
Mechanistic
0.720
0.720
Evidence
0.750
0.660
Novelty
0.800
0.700
Feasibility
0.450
0.700
Impact
0.550
0.700
Druggability
0.400
0.650
Safety
0.350
0.700
Competition
0.650
0.650
Data
0.700
0.750
Reproducible
0.580
0.700
KG Connect
0.500
0.500
Evidence
Exosomal α-Synuclein as an Interneuronal Propagation Vector
No evidence citations yet
Rab27A/B-mediated exosomal tau secretion from microglia driv
No evidence citations yet
Debate Excerpts
Exosomal α-Synuclein as an Interneuronal Propagati
4 rounds · quality: 0.81
Theorist
# Legacy Pre-Pipeline Hypotheses: Neurodegeneration
---
## Hypothesis 1: Exosomal α-Synuclein as an Interneuronal Propagation Vector in Parkinson's Disease
**Mechanism:** Misfolded α-synuclein (aSy...
Skeptic
# Critical Evaluation of Legacy Pre-Pipeline Hypotheses
## General Methodological Concerns (Cross-Cutting Issues)
Before evaluating individual hypotheses, several systemic weaknesses affect the enti...
Domain Expert
# Comprehensive Feasibility Assessment: Legacy Neurodegeneration Hypotheses
## Preamble
This assessment evaluates each hypothesis across five critical domains using a standardized framework. Evidenc...
Synthesizer
```json
{
"ranked_hypotheses": [
{
"title": "TREM2-Deficient Microglia as Drivers of Amyloid Plaque Toxicity in Alzheimer's Disease",
"description": "TREM2 loss-of-function variants ...
Rab27A/B-mediated exosomal tau secretion from micr
4 rounds · quality: 0.66
Theorist
# Therapeutic and Mechanistic Hypotheses: Tau Propagation Mechanisms Across Brain Regions and Disease Stages
---
## Hypothesis 1: Synaptic Transmission Predominates in Early-Stage Limbic Propagation...
Skeptic
# Critical Evaluation of Tau Propagation Hypotheses
## Hypothesis 1: Synaptic Transmission in Early-Stage Limbic Propagation
### Weak Links
- **Mechanistic specificity**: The claim of "predominance"...
Domain Expert
# Feasibility Assessment: Tau Propagation Hypotheses
## Executive Summary
The debate has generated six mechanistically distinct hypotheses with revised confidence scores ranging from 0.56 to 0.67. T...
Synthesizer
```json
{
"ranked_hypotheses": [
{
"title": "VPS35 retromer activation prevents endosomal tau templating across all brain regions and disease stages",
"description": "Retromer dysfun...